Answers are grounded in this paper and cite their sources.
T lymphocytes and further discuss how we can target these cells as a new therapeutic strategy to infectious and autoimmune/inflammatory diseases.
No takes yet. Share an insight, caveat, or question.
Takeshi Kawabe (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: